Beyond Diagnostics

Beyond Diagnostics is a pioneering Swiss deep-tech company dedicated to revolutionizing medication quality verification. Focusing on point-of-care solutions, Beyond Diagnostics ensures the stability and effectiveness of sensitive medicines throughout their journey, from production to patient use. With an initial focus on insulin, a critical therapy for millions globally, Beyond Diagnostics envisions expanding its reach to safeguard all fragile medicines used outside clinical settings.

Supported by Innosuisse, Beyond Diagnostics is committed to making medication quality transparent, empowering patients, clinicians, and partners to enhance treatment safety and sustainability. The company operates primarily from its Bern, CH address, with an additional location in Zürich, CH. By prioritizing innovation and quality, Beyond Diagnostics aims to set new standards in the healthcare industry, ensuring that medication quality is as clear as clean water.

Beyond Diagnostics is poised to make significant advancements in the medical field, improving patient outcomes and fostering greater confidence in medication efficacy. We invite the manager of Beyond Diagnostics to create a customized and exclusive company showcase and product listing on our platform, further amplifying your impact and reach.